Here is a question about this article: Sparta remained independent, but it was no longer the leading military power in the Peloponnese. The Spartan king Cleomenes III (235–222 BCE) staged a military coup against the conservative ephors and pushed through radical social and land reforms in order to increase the size of the shrinking Spartan citizenry able to provide military service and restore Spartan power. Sparta's bid for supremacy was crushed at the Battle of Sellasia (222) by the Achaean league and Macedon, who restored the power of the ephors.
What is the answer to this question: I couldn't could up with another question. But i need to fill this space because I can't submit the hit. 
****
So... refor


Here is a question about this article: Few Chinese had any illusions about Japanese designs on China. Hungry for raw materials and pressed by a growing population, Japan initiated the seizure of Manchuria in September 1931 and established ex-Qing emperor Puyi as head of the puppet state of Manchukuo in 1932. During the Sino-Japanese War (1937–1945), the loss of Manchuria, and its vast potential for industrial development and war industries, was a blow to the Kuomintang economy. The League of Nations, established at the end of World War I, was unable to act in the face of the Japanese defiance. After 1940, conflicts between the Kuomintang and Communists became more frequent in the areas not under Japanese control. The Communists expanded their influence wherever opportunities presented themselves through mass organizations, administrative reforms, and the land- and tax-reform measures favoring the peasants—while the Kuomintang attempted to neutralize the spread of Communist influence.
What is the answer to this question: What dealt a blow to the Kuomintang economy?
****
So... loss of Manchuria, and its vast potential for industrial development and war industries,


Here is a question about this article: In many non-US western countries a 'fourth hurdle' of cost effectiveness analysis has developed before new technologies can be provided. This focuses on the efficiency (in terms of the cost per QALY) of the technologies in question rather than their efficacy. In England and Wales NICE decides whether and in what circumstances drugs and technologies will be made available by the NHS, whilst similar arrangements exist with the Scottish Medicines Consortium in Scotland, and the Pharmaceutical Benefits Advisory Committee in Australia. A product must pass the threshold for cost-effectiveness if it is to be approved. Treatments must represent 'value for money' and a net benefit to society.
What is the answer to this question: What is the name of the organization in Scotland that decides the availability of drugs?
****
So...
Scottish Medicines Consortium